Periodic Reporting for period 1 - BRAVE (VD-1: World's first autonomous blood drawing device)
Reporting period: 2020-01-01 to 2020-12-31
The VD-1 can autonomously draw blood from patients. Willingness to use a device is very high. The majority of patients visiting the hospital for a blood draw are willing to try the VD-1. For laboratories, the VD-1 will reduce diagnostic errors because of standardization of the process. Moreover, labs can save on operational cost and increase capacity. The benefits are clear to our (European) potential customers, who have invested, signed letters of intent to purchase and are keen to collaborate.
The technology of the VD-1 (three patents applied) consists of real-time image recognition software based on AI, tested on a vast number of images, able to create a 3D vein image despite difficult conditions. Advanced robotic positioning ensures high needle precision, impossible to achieve by a human. For ultimate safety, the needle position can be adjusted based on patient movements. The overall objectives of the BRAVE project are to optimize prototype 2 and test this optimization in the BRAVE trial, subsequently industrialize and validate the positioning system with as result the fabrication of the 0-series.
In software, we have strengthened our deep learning architecture. We also developed and improved detection strategies which were also tested in our clinical study. Last, we improved our software architecture, including also selection of our operating system and design of safety systems.
In exploitation, we further expanded our European network of potential customers and partners. We also applied for additional patents.
Last, we have updated our planning and project management. We have grown the team from 15 to 27 highly skilled people and raised additional private funding.
Through this project, we will able to automate an invasive medical procedure. This is breakthrough progress beyond the state of the art that has not been seen before in healthcare, which can help to alleviate the shortage of nursing personnel in Europe and beyond.
By automation we can more easily scale up resources in our global healthcare systems and increase their resiliency. This project forms the basis of a shifting paradigm.